In the United States, Walgreens Boots Alliance’s Retail Pharmacy division finished the year with total sales of $81 billion — up 6% over fiscal 2014 — driven by total comparable store sales growth of 6.4%
“Today’s announcement is another step in Walgreens Boots Alliance’s global development and continues our profitable growth strategy," Stefano Pessina, Walgreens Boots Alliance executive vice chairman and CEO, said.
A deal would bring the No. 1 and No. 3 retail pharmacy operations under one roof, creating a pureplay pharmacy operator with more than 12,786 stores and more than $67.1 billion in pharmacy revenue, according to figures from DSN's Annual PoweRx Industry Rankings.
Walgreens has placed its plans to expand Theranos bloodwork centers on hold, USA Today confrimed in a report published Saturday. Walgreens spokesperson Markeisha Marshall wrote an email to USA Today saying that "with the completion of our Phoenix rollout that was part of our current agreement with Theranos, we are currently in discussions about the next phase of our relationship." (USA Today)